All In Biotech

Drug Trial Radar · NCT04329728

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

An Open Label, Phase 1/2 Study Evaluating Immunomodulatory AVM0703 in Patients With Lymphoid Malignancies (OPAL Study)

Last checked: Nov 19, 2026Latest source record: Apr 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

144

Planned (sponsor's estimate)

Start

Nov 6, 2020

Primary completion

Nov 30, 2027

Study completion Dec 1, 2028

Sponsor

Lead sponsor
AVM Biotechnology IncIndustry
Sponsor type
Industry
Collaborators
Medpace, Inc.
First posted
Apr 1, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 95 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of AVM0703 administered as a single intravenous (IV) infusion to patients with lymphoid malignancies.

Conditions

  • Lymphoid Malignancies

Interventions

  • AVM0703Drug

    Intravenous infusion over \~1 hours

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Phase 1: incidence of Adverse eventsTime frame: Year One

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • City of Hope

    Duarte, California · Recruiting

  • Los Angeles Cancer Network

    Los Angeles, California · Recruiting

  • UCLA Medical Center of Hematology/Oncology

    Los Angeles, California · Recruiting

  • Innovative Clinical Research Institute

    Whittier, California · Recruiting

  • ASCLEPES Research Centers

    Weeki Wachee, Florida · Recruiting

  • University of Illinois at Chicago Cancer Center

    Chicago, Illinois · Recruiting

  • Norton Cancer Institute

    Louisville, Kentucky · Recruiting

  • Oncology Hematology West P.C. dba Nebraska Cancer Specialists

    Omaha, Nebraska · Recruiting

  • Gabrail Cancer Center Research,

    Canton, Ohio · Recruiting

  • Baptist Clinical Research Institute

    Memphis, Tennessee · Recruiting

  • University of Texas(UT) Southwestern-Children's Medical Center

    Dallas, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.